HONG KONG, Aug. 30 /PRNewswire/ -- OrbusNeich today announced that Dr. Robbert de Winter, M.D., Ph.D., a leading interventional cardiologist with the Academic Medical Center in Amsterdam, will present the pros and cons of drug- eluting stents and the benefits of using an alternative pro-healing stent to physicians in a workshop at next week’s ESC Congress 2007 in Vienna.
Sponsored by OrbusNeich, the workshop will take place at 12:45 p.m. CEST on Sept. 3 in the Helsinki room in Zone 2 of the Messe Wien Conference Center. The program will include de Winter’s presentation of the latest post-marketing data on the performance of a pro-healing stent in cases worldwide.
The ESC Congress is a unique forum where medical professionals can meet their colleagues from all around the world and exchange ideas and information in the field of cardiovascular medicine. The best recent scientific developments and novel research will be presented to medical professionals who deal with cardiovascular diseases in the course of their professional activity.
About OrbusNeich
OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company’s portfolio includes a pro-healing stent that uses immobilized antibodies to capture circulating endothelial progenitor cells, which rapidly form an endothelial layer over the stent.
A global company, OrbusNeich is headquartered in Hong Kong and has operations in Fort Lauderdale, Fla.; Hoevelaken, The Netherlands; and Shenzhen, China. OrbusNeich, which has provided cardiology devices to physicians through its predecessor companies since 1979, today supplies products in more than 60 countries. For more information, visit www.OrbusNeich.com.
OrbusNeich
CONTACT: David Schull of Russo Partners LLC, +1-212-845-4271 (office),+1-858-717-2310 (mobile), david.schull@russopartnersllc.com, or BenjaminCarmichael, +1-212-845-4242, benjamin.carmichael@russopartnersllc.com, bothfor OrbusNeich
Web site: http://www.OrbusNeich.com/
